Biofrontera Stock Performance
| BFRI Stock | USD 0.93 0.06 6.03% |
The firm shows a Beta (market volatility) of 1.49, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biofrontera will likely underperform. At this point, Biofrontera has a negative expected return of -0.0785%. Please make sure to confirm Biofrontera's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Biofrontera performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Biofrontera has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Biofrontera is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor 1:20 | Last Split Date 2023-07-05 |
1 | Biofrontera Inc. announces sale of license to Xepi Antibiotic Cream to Pelthos Therapeutics Inc. for up to 10M | 11/07/2025 |
2 | Will Biofrontera Inc. stock benefit from commodity supercycle - Portfolio Profit Report Weekly Hot Stock Watchlists - newser.com | 11/19/2025 |
3 | Insider Trading | 11/21/2025 |
4 | Biofrontera Inc. Announces Filing of Supplemental New Drug Application for the Treatment of Superficial Basal Cell Carcinoma with Ameluz-PDT | 12/02/2025 |
5 | Last Patient Completes Biofronteras Phase 1 Pharmacokinetics Study of Ameluz for Treatment of Actinic Keratoses on the Trunk and Extremities | 12/04/2025 |
6 | How Biofrontera AG stock responds to bond market - Price Action Risk Controlled Daily Plans - ulpravda.ru | 12/19/2025 |
7 | Guidance Update Can Biofrontera Inc Equity Warrant stock maintain growth trajectory - Weekly Earnings Recap Growth Oriented Trading Recommendations - moha.gov.v... | 12/29/2025 |
8 | Can Biofrontera Inc. Equity Warrant stock deliver strong Q4 earnings - Weekly Profit Summary Community Consensus Trade Signals - ulpravda.ru | 01/09/2026 |
9 | B8F.DE Biofrontera AG 2000 percent to 6.80 after hours 15 Jan 2026 heavy volume - Meyka | 01/15/2026 |
10 | After Hours 21 Jan 2026 B8F.DE Biofrontera AG 6.80 on 45,797 volume - Meyka | 01/21/2026 |
11 | B8F.DE Biofrontera AG XETRA 6.804 intraday jump 28 Jan 2026 watch volume - Meyka | 01/28/2026 |
| Begin Period Cash Flow | 1.5 M | |
| Total Cashflows From Investing Activities | -3000.00 |
Biofrontera | Build AI portfolio with Biofrontera Stock |
Biofrontera Relative Risk vs. Return Landscape
If you would invest 110.00 in Biofrontera on November 2, 2025 and sell it today you would lose (16.97) from holding Biofrontera or give up 15.43% of portfolio value over 90 days. Biofrontera is currently does not generate positive expected returns and assumes 6.433% risk (volatility on return distribution) over the 90 days horizon. In different words, 57% of stocks are less volatile than Biofrontera, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biofrontera Target Price Odds to finish over Current Price
The tendency of Biofrontera Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.93 | 90 days | 0.93 | about 32.22 |
Based on a normal probability distribution, the odds of Biofrontera to move above the current price in 90 days from now is about 32.22 (This Biofrontera probability density function shows the probability of Biofrontera Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.49 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biofrontera will likely underperform. Additionally Biofrontera has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Biofrontera Price Density |
| Price |
Predictive Modules for Biofrontera
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biofrontera. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biofrontera Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biofrontera is not an exception. The market had few large corrections towards the Biofrontera's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biofrontera, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biofrontera within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 1.49 | |
σ | Overall volatility | 0.13 | |
Ir | Information ratio | -0.01 |
Biofrontera Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biofrontera for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biofrontera can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biofrontera generated a negative expected return over the last 90 days | |
| Biofrontera has high historical volatility and very poor performance | |
| Biofrontera has some characteristics of a very speculative penny stock | |
| Biofrontera has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 37.3 M. Net Loss for the year was (17.76 M) with profit before overhead, payroll, taxes, and interest of 23.94 M. | |
| Biofrontera currently holds about 31.91 M in cash with (10.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biofrontera has a poor financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: B8F.DE Biofrontera AG XETRA 6.804 intraday jump 28 Jan 2026 watch volume - Meyka |
Biofrontera Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biofrontera Stock often depends not only on the future outlook of the current and potential Biofrontera's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biofrontera's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.5 M | |
| Cash And Short Term Investments | 5.9 M |
Biofrontera Fundamentals Growth
Biofrontera Stock prices reflect investors' perceptions of the future prospects and financial health of Biofrontera, and Biofrontera fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biofrontera Stock performance.
| Return On Equity | -11.92 | ||||
| Return On Asset | -0.65 | ||||
| Profit Margin | (0.47) % | ||||
| Operating Margin | (0.90) % | ||||
| Current Valuation | 12.95 M | ||||
| Shares Outstanding | 11.65 M | ||||
| Price To Book | 0.65 X | ||||
| Price To Sales | 0.31 X | ||||
| Revenue | 37.3 M | ||||
| Gross Profit | 23.94 M | ||||
| EBITDA | (14.44 M) | ||||
| Net Income | (17.76 M) | ||||
| Cash And Equivalents | 31.91 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 4.92 M | ||||
| Current Ratio | 3.16 X | ||||
| Book Value Per Share | (0.22) X | ||||
| Cash Flow From Operations | (10.27 M) | ||||
| Earnings Per Share | (1.50) X | ||||
| Market Capitalization | 11.49 M | ||||
| Total Asset | 22.1 M | ||||
| Retained Earnings | (117.41 M) | ||||
| Working Capital | 8.68 M | ||||
About Biofrontera Performance
By evaluating Biofrontera's fundamental ratios, stakeholders can gain valuable insights into Biofrontera's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biofrontera has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biofrontera has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 149.93 | 229.60 | |
| Return On Tangible Assets | (0.93) | (0.97) | |
| Return On Capital Employed | (1.96) | (2.06) | |
| Return On Assets | (0.92) | (0.97) | |
| Return On Equity | (4.61) | (4.84) |
Things to note about Biofrontera performance evaluation
Checking the ongoing alerts about Biofrontera for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biofrontera help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biofrontera generated a negative expected return over the last 90 days | |
| Biofrontera has high historical volatility and very poor performance | |
| Biofrontera has some characteristics of a very speculative penny stock | |
| Biofrontera has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 37.3 M. Net Loss for the year was (17.76 M) with profit before overhead, payroll, taxes, and interest of 23.94 M. | |
| Biofrontera currently holds about 31.91 M in cash with (10.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biofrontera has a poor financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: B8F.DE Biofrontera AG XETRA 6.804 intraday jump 28 Jan 2026 watch volume - Meyka |
- Analyzing Biofrontera's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biofrontera's stock is overvalued or undervalued compared to its peers.
- Examining Biofrontera's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biofrontera's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biofrontera's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biofrontera's stock. These opinions can provide insight into Biofrontera's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biofrontera Stock analysis
When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |